Search

everythinglearnresearchcommunity

for

Search:↓

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Short telomeres contribute to aging and cancer, and while telomerase can delay aging, it may also promote cancer.

New treatments for skin conditions in children include a preferred drug for birthmark reduction, proactive creams for eczema and vitiligo, a safe psoriasis medication, and special tissues and socks for eczema and fungal infections.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Gray hair can potentially be reversed, leading to new treatments.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Hidradenitis Suppurativa is likely an autoinflammatory disease, and better understanding its causes could improve treatments.

2011 dermatology discussions highlighted stem cell hair treatments, new lichen planopilaris therapies, skin side effects from cancer drugs, emerging allergens, and the link between food allergies and skin issues.

Research on hair disorders has advanced, with promising future progress in understanding and treating these conditions.

Active oxygen scavengers can reverse the suppression of hair cell growth caused by androgens.

Different substances affect hair and skin cell growth in various ways.

Eating less sugar, milk, and saturated fats and more vegetables and fish may help treat and prevent acne.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Antidepressants might help with skin inflammation and improve conditions like psoriasis and eczema.

The composition with carnitine, thioctic acid, and saw palmetto extract may effectively reduce inflammation in hair follicle cells.

The document concludes that changes in eyelashes and eyelid skin can indicate various local and systemic diseases.

Early diagnosis and combination therapy, especially with finasteride and dutasteride, are key to managing Frontal Fibrosing Alopecia effectively.

Heredity and hormones cause common hair loss, and topical minoxidil is the first recommended treatment.

A compound from Calophyllum inophyllum L. leaf may help treat non-small cell lung cancer.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

A woman developed hair loss after starting a treatment with adalimumab, suggesting this medication might cause hair loss.

Removing UBE2N from skin cells causes inflammation and immune response, which can be lessened with specific inhibitors.

Ruxolitinib treatment may cause eyelash growth.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Coumarin derivatives show promise as anti-estrogenic agents for treating breast cancer, with some in clinical trials.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

New drugs for rheumatoid arthritis show improvement but have side effects and are not a cure.

Certain immune cells in the skin can stop hair from growing.